Indeed, dysregulated Pi may be a potential common risk factor mediating associations between elevated levels of FGF23, kidney stones, and renal cell carcinoma, and more research is needed in these areas. This evidence concerns the gene FGF23 and hereditary clear cell renal cell carcinoma.